Navigation Links
Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
Date:7/1/2008

Jury verdict in Montgomery County Circuit Court awards $33 million in

compensatory damages Jury decides in favor of Novartis and rejects claims for punitive damages NPC maintains it reported true and accurate prices and will file appeal

EAST HANOVER, N.J., July 1 /PRNewswire/ -- Novartis Pharmaceuticals Corporation (NPC) today announced it will appeal a verdict in the Montgomery County Circuit Court. Novartis disputes the State of Alabama's claims that the prices provided by NPC to reporting services resulted in overpayment to pharmacists and doctors in the Alabama State Medicaid system.

NPC was among 73 pharmaceutical manufacturers named in a lawsuit filed in 2005 by the Alabama Attorney General, claiming that the average wholesale price (AWP) and wholesale acquisition cost (WAC) provided by pharmaceutical companies to price reporting services resulted in overpayment to pharmacists and doctors in the State Medicaid system. The jury rejected the State's claims for punitive damages but decided against NPC on the State's claims for compensatory damages, awarding $33 million.

NPC believes Alabama's claims were unfounded because it reported true and accurate prices, based on terms that have been known and used by all participants in pharmaceuticals markets, including Alabama Medicaid, for more than 30 years.

Disclaimer

The foregoing release contains forward-looking statements that can be identified by terminology such as "to Appeal," "will," "believes," or similar expressions, or by express or implied discussions regarding the potential outcome of the forthcoming appeal in the litigation which is the subject of this press release, or of the potential outcome of any other pricing litigation. Such forward-looking statements reflect the current views of the Company regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materia
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Novartis Vaccines Launches National Gift-Giving Program to Help Protect Loved Ones by Reserving an Influenza Vaccination
2. Colorado Influenza and Pneumococcal Alert Coalition (CIPAC) Partners with Novartis Vaccines for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
3. Novartis Vaccines Partners With RediClinic for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
4. Novartis Vaccines to Host Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
5. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
6. Novartis and Sony Pictures Television Internationals Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America
7. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
8. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
9. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
10. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
11. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...Assembly Member Tom Torlakson Introduces AB 89 , ...ire/ -- Today, Lung Cancer Alliance-California (...lakson (D-11th District) for his continued leaders...or lung cancer research. For the third consecutiv...search is being considered in the California Legis...
(Date:1/8/2009)...pts Prenatal Solution Key Factor in Decision for F...RLANDO, Fla., Jan. 8 All...LLC, one of the largest multi-specialty group prac... the Allscripts Enterprise(TM) Electronic Health R...cians in 18 offices across Central Florida. , ...
(Date:1/8/2009)... St. Jude Children,s Research Hospital have demons...eumonia following influenza. They found that the a...l bacteria by inhibiting their protein synthesis, ...tment with the "beta-lactam" antibiotic ampicillin..., The finding is important because pneumonia, rat...
(Date:1/8/2009)..., Jan. 8 Allscripts-Misy... Healthcare Solutions, Inc. (Allscripts or,the Co...the three and six,months ended November 30, 2008....rnh/20061005/ALLSCRIPTSLOGO-b ) , The Compa...vember 30, 2008,include results from legacy Allsc...
Breaking Medicine News(10 mins):Health News:Lung Cancer Alliance Applauds New Legislation Funding Lung Cancer Research 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 3Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 4Health News:Study finds more effective treatment for pneumonia following influenza 2Health News:Study finds more effective treatment for pneumonia following influenza 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 13
... from Wake Forest University School of Medicine ha...lar// that reducing injury to the aorta which may... the development of complications to the heart whi... feel by following a technique which reduces injur...
...istwatch invented by South Africa's Gervan Lubbe w...t to be a health hazard. They have warned that the...s diseases like HIV/AIDS.// There are some who hav...an really perform functions like detecting disease...
...y four Marlboro smokers for hi-tech screenings aim... people are demanding that the company pay for spi... were to be brought into force, it will serve to s...etection. The company has been accused of indulgin...
...versity of New South Wales scientists resulted in ...ment can be life threatening and resulted in early...gh because //they identified that the patients who...ffer a progression of the disease, compared with t...
Other Medicine News:Health News:Breaks In The HIV Treatment Resulted In Devastating Results. 2
(Date:1/8/2009)...e in an ongoing Phase Ib trial demonstrated a 2.5 ..., , Conference Call Today at 8:30AM EST , , ... Pharmaceuticals, Inc. (Nasdaq: ANDS ) today ann... Phase Ib clinical trial of ANA598, the Company,s ...r. ANA598 was very well-tolerated and demonstrate...
(Date:1/7/2009)...ease , , WHITE PLAINS, N.Y., Jan. 7 /PRNewswire...that the decades-long rise in the United States pr...han ever at increased risk of death and disability...3,000 babies were born too soon in 2006, according...ch today released "Births: Final data for 2006," N...
(Date:1/7/2009)...ntan Puhua Hospital Stem Cells Center ( http://www...ng stem cells to effectively treat neurological di...ced additions to its medical and research staff th...apabilities for growing numbers of incoming intern...he distinguished Dr. Jiang Ping, who was named Chi...
(Date:1/6/2009)...ntaining a healthy immune system , , PURCHASE, ...study in Nutrition and Cancer (60(5), 643-651) b...a, Japan has shown that AHCC (Active Hexose Correl...ing the number of dendritic cells (DCs). DCs are a...senting foreign substances to other immune system ...
Breaking Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Preterm Births Rise 36 Percent Since Early 1980s 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Delayed angioplasty big bucks no bang 5485 1Delayed angioplasty big bucks no bang 5485 2Genelabs Technologies to Present at the Acumen Biofin Rodman 26 Renshaw 9th Annual Healthcare Conference 5482 1Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 1Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 2Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 3Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 4Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 5Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 6Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 7Oncology Physician Resource 28OPR 29 Extends Agreement With OTN and Onmark as Oncology Services Partner 5476 1Oncology Physician Resource 28OPR 29 Extends Agreement With OTN and Onmark as Oncology Services Partner 5476 2Oncology Physician Resource 28OPR 29 Extends Agreement With OTN and Onmark as Oncology Services Partner 5476 3
...7 /PRNewswire-FirstCall/ -- Vanda,Pharmaceuticals ...f,the Henry Ford Sleep Disorders and Research Cent...on on recent Phase III clinical,trial results for ...ptor agonist, at SLEEP 2007, the 21st annual meeti... (APSS). , The Vanda presentation will take place ...
...IRE)--Jun 8, 2007 - Archemix Corp., a,biotechnolog...tamers, announced the successful completion of a P...1779. ARC1779 is designed to,selectively block the... by inhibiting the binding of von Willebrand Facto...ed vWF is scientifically,recognized as the first s...
Other Medicine Technology:Vanda Pharmaceuticals To Present Data on VEC-162 at SLEEP 2007, the,Annual Meeting of the Associated Professional Sleep Societies 2Archemix Announces Completion of Phase 1 Trial of ARC1779 2Archemix Announces Completion of Phase 1 Trial of ARC1779 3
...tome Semi-Automatic Tissue Sectioning System has m...ctioning system. Researchers from around the globe...ir fresh and fresh fixed tissue sectioning needs f...issue Sectioning Systems, the biological viability...
...3000 Deluxe Sectioning System provides a versatile...ant tissues. The 3000 employs a vibrating blade p...or embedding. The creation of artifacts, the alte...tivities, and other deleterious effect inherent in...
The Vibratome comes standard with a square vice mounting device. These specimen blocks are utilized for mounting specimens and placing in the Vibratome holding vice. The blocks are annodized black
These specialty razor blades are feather thin and very sharp. Most users have found an increased quality level in Vibratome sections with these blades.
Medicine Products: